title: Hypomethylation of PRAME promoter is associated with poor prognosis in myelodysplastic syndrome.
authors.forename: Jun
authors.initials: J
authors.lastname: Qian
authors.forename: Zhao-hui
authors.initials: ZH
authors.lastname: Zhu
authors.forename: Jiang
authors.initials: J
authors.lastname: Lin
authors.forename: Dong-Ming
authors.initials: DM
authors.lastname: Ming Yao
authors.forename: Yun
authors.initials: Y
authors.lastname: Li
authors.forename: Jing
authors.initials: J
authors.lastname: Yang
authors.forename: Cui-Zhu
authors.initials: CZ
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000235:genetics*; D019175:DNA Methylation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics; D016019:Survival Analysis; D055815:Young Adult
chemical_list: D000951:Antigens, Neoplasm; C404944:PRAME protein, human